Link Pharma Chem Limited
BSE:524748
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (37.9), the stock would be worth ₹-15.13 (152% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -72.5 | ₹29 |
0%
|
| Industry Average | 37.9 | ₹-15.13 |
-152%
|
| Country Average | 35.9 | ₹-14.35 |
-149%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
L
|
Link Pharma Chem Limited
BSE:524748
|
128.8m INR | -72.5 | 95 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 29.6 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | -122.7 | 41.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
28.4B USD | -28.5 | -10.9 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | -74.9 | 24.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
23.6B USD | 85.6 | -31.9 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
726.5B TWD | -296.7 | 160.8 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
156.4B CNY | 12.1 | 17.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.9T KRW | -8.2 | -17.5 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
136.3B CNY | 39.3 | 185.1 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
120.7B CNY | 218.9 | 42.1 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 20.7 |
| Median | 35.9 |
| 70th Percentile | 64.8 |
| Max | 50 585.9 |
Other Multiples
Link Pharma Chem Limited
Glance View
Link Pharma Chem Ltd. engages in the manufacture and sale of intermediates for the pharmaceutical, agro, and specialty chemical industries. The company is headquartered in Nandesari, Gujarat. The firm is engaged in the manufacturing and selling of organic intermediates which are used in pharmaceuticals, agro and specialty chemical industries. The firm is also engaged in custom synthesis / contract manufacturing for multistage synthesis for small, medium, and large companies. The firm's geographical segments include India and Outside India. The company offers services, such as contract manufacturing facilities, development of multi-step pathways for organic synthesis, and refinement and optimization of existing synthetic methods. The firm's in-house testing laboratory has various facilities, such as high-performance liquid chromatography (HPLC) testing facilities, ultraviolet (UV) spectrophotometer testing facilities, Karl-Fisher instruments for moisture/water content measurement, and gas liquid chromatography (GLC) testing facilities. Its manufacturing facility is located at Nandesari in Gujarat.
